IMMUcan – EORTC Research Project 1828- aims to generate broad molecular (WES and RNAseq) and cellular profiling data(multiplex IF and IMC) to better understand the tumor and its microenvironment, and the impact of current therapeutic interventions.
The project will recruit 3000 patients with head and neck squamous cell carcinoma (HNSCC), non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), colorectal carcinoma (CRC), and Breast cancers (BC) via SPECTA, as well as thanks to collaborations with ongoing European external clinical trials for access to samples of utmost interest for the project.
For each patient enrolled, a free molecular report is generated within 6 weeks, containing the clinically relevant molecular alterations.
LIST OF COHORTS
For SPECTA, please enroll patients with the tumor type specified in the table, ONLY when the status is green. You can enroll those patients by clicking on the , next to the green status.
Study specific information (HBM, Project Specific selection criteria, CRF completion guidelines…) can be found here . Please note that your electronic database ORTA password is required for access (protocol 1553).
For any questions, please contact the project address: firstname.lastname@example.org.
To view the List of Cohorts, please flip your mobile phone horizontally: